- Business Wire•3 days agoSiemens Healthineers and Biogen Announce Agreement to Jointly Develop New MRI Tools for Multiple Sclerosis
Siemens Healthineers and Biogen have announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients. Siemens Healthineers aims to enable healthcare providers to meet their current challenges and excel in their respective environments.
- Capital Cube•7 days ago
Categories: Yahoo Finance Get free summary analysis Siemens Ltd. reports financial results for the year ended September 30, 2016. Highlights Gross margins narrowed from 13.28% to 13.22% compared to the same period last year, operating (EBITDA) margins now 7.36% from 7.92%. Change in operating cash flow of -7.24% compared to same period last year is about the same ... Read more (Read more...)
- Business Wire•14 days ago
Materialise NV (Nasdaq:MTLS) announced today that it has signed an agreement with Siemens’ product lifecycle management (PLM) software business, to help create a seamless process for designing and manufacturing parts using additive manufacturing technology. Through this agreement, the two companies will work together to integrate Materialise’s industry-proven AM software technologies with Siemens’ digital solutions. Siemens and Materialise are technology leaders who share the vision that Additive Manufacturing will revolutionize the industry.
SIEMENS.BO: Summary for SIEMENS LTD. - Yahoo Finance
Siemens Limited (SIEMENS.BO)
BSE - BSE Delayed price. Currency in INR
Add to watchlist
|Day's range||1,147.55 - 1,181.50|
|52-week range||969.00 - 1,355.40|
|PE ratio (TTM)||35.04|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|